Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon et al

被引：51

作者：

Kaaja, R ^{[1
]}

Julkunen, H

机构：

[1] Helsinki Univ Hosp, Helsinki, Finland

[2] Peijas Hosp, Vantaa, Finland

来源：

ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 01期

关键词：

D O I：

10.1002/art.10716

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：280 / 281

页数：2

共 12 条

[1]

BUYON J, 1988, J RHEUMATOL, V15, P1104

[2] IN-UTERO IDENTIFICATION AND THERAPY OF CONGENITAL HEART-BLOCK [J].

BUYON, JP ;

WALTUCK, J ;

KLEINMAN, C ;

COPEL, J .

LUPUS, 1995, 4 (02) :116-121

[3]

Buyon JP, 2001, ARTHRITIS RHEUM-US, V44, P1723, DOI 10.1002/1529-0131(200108)44:8<1723::AID-ART305>3.0.CO

[4]

2-0

[5] Short-and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn [J].

Eronen, M ;

Sirèn, MK ;

Ekblad, H ;

Tikanoja, T ;

Julkunen, H ;

Paavilainen, T .

PEDIATRICS, 2000, 106 (01) :86-91

[6]

Julkunen H, 2001, ARTHRITIS RHEUM-US, V44, P487, DOI 10.1002/1529-0131(200102)44:2<487::AID-ANR70>3.3.CO

[7]

2-4

[8]

KAAJA R, 1991, AM J OBSTET GYNECOL, V165, P1333

[9] Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. [J].

Kazatchkine, MD ;

Kaveri, SV .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (10) :747-755

[10]

Sirén MK, 1998, J RHEUMATOL, V25, P1862

← 1 2 →